Season 2 · Episode 7
7: Dealcast: Covid-19 and healthcare M&A
Dealcast: The M&A Podcast · Anthony Phillips
April 29, 202018m 26s
Audio is streamed directly from the publisher (podcast.wistia.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
No sector is closer than healthcare to the front-lines of the covid-19 pandemic.
Not only is the pandemic shaking up businesses in the sector, it is creating opportunities for dealmaking. Indeed, Thermo Fisher’s [NYSE:TMO] proposed takeover of diagnostics firm Qiagen [NYSE:QGEN] shows how the crisis can make the case for M&A.
In this week’s podcast, Mergermarket healthcare editor Mintoi Chessa-Florea, Mergermarket healthcare reporter Davide Salvi and Dealreporter analyst William Cain join us to discuss the sector. At issue are: pre-covid-19 M&A trends, the effect of the pandemic on business cases, the effect of the pandemic on M&A and ECM, and the outlook for Qiagen/Thermo Fisher.